Table 3.
Major primary outcome measures of the analysed studies
| Primary outcome measure | Total number of studies including the outcome (%) | Number of studies with positive clinical outcome (%) |
| Impact on patients | ||
| Number of inappropriate prescriptions | 11 (26.2) | 5 (45.5) |
| Resolution rate of medical problems identified | 4 (9.5) | 3 (75.0) |
| Risk score assessment | 4 (9.5) | 2 (50.0) |
| Number of (re)-hospitalisations | 3 (7.1) | 2 (66.7) |
| Asthma control | 2 (4.8) | 2 (100.0) |
| Acute kidney injury progression | 2 (4.8) | 2 (100.0) |
| Impact on glycaemic control | 2 (4.8) | 1 (50.0) |
| Delirium duration and severity | 1 (2.4) | 0 (0.0) |
| Feasibility of the intervention and patient satisfaction | 1 (2.4) | 0 (0.0) |
| Patient-clinician medication-related communication | 1 (2.4) | 1 (100.0) |
| Number of adverse drug events | 1 (2.4) | 0 (0.0) |
| Overall studies | 32 (76.2) | 18 (56.2) |
| Impact on clinicians | ||
| Prescription rate of drugs of interest | 3 (7.1) | 1 (33.3) |
| Compliance with epidural infusion initiation | 1 (2.4) | 1 (100.0) |
| Diagnosis accuracy | 1 (2.4) | 1 (100.0) |
| Hypertension recognition | 1 (2.4) | 1 (100.0) |
| Time to administration of intravenous antibiotics | 1 (2.4) | 1 (100.0) |
| Overall studies | 7 (16.7) | 5 (71.4) |
| Impact on healthcare setting | ||
| Number of appropriate ferritin test orders | 1 (2.4) | 1 (100.0) |
| Number of feeding tube-related medication errors | 1 (2.4) | 1 (100.0) |
| Percentage of vital signs documented | 1 (2.4) | 0 (0.0) |
| Overall studies | 3 (7.1) | 2 (66.7) |
| Total number of studies | 42 (100.0) | 25 (59.5) |